Gyermekkori daganatok: vizsgálatok itt: Kína
611 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 1. fázisCsak meghívásosA Clinical Study of HY035 Cell Injection in the Treatment of CD7-positive Relapsed or Refractory Hematologic Malignancies
- Where
- Tianjin
- Életkor
- 3 év to 70 év
- People
- 13
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07784309 - 1/2. fázisTaking peopleAPG-115 Alone or in Combination With APG-2575 in Recurrent or Refractory Neuroblastoma or Solid Tumors
- Where
- Guangzhou, Tianjin, Wuhan
- Életkor
- 5 év and over
- People
- 100
- Run by
- Ascentage Pharma Group Inc.
See details and how to joinNCT05701306 - No phaseTaking peopleFertility Sparing Therapy for Patients With Stage IA G2 Endometrial Cancer
- Where
- Beijing
- Életkor
- Up to 45 év
- People
- 16
- Run by
- Peking University People's Hospital
See details and how to joinNCT06468215 - Korai 1. fázisTaking peopleSafety, Tolerability, and Preliminary Efficacy of [211At]MABG in Patients With Relapsed or Refractory Neuroblastoma
- Where
- Chengdu
- Életkor
- 1 év to 100 év
- People
- 10
- Run by
- Sichuan University
See details and how to joinNCT07767630 - No phaseTaking peopleSafety and Efficacy of Cryoablation for Thyroid Tumors
- Where
- Beijing
- People
- 108
- Run by
- Yukun Luo
See details and how to joinNCT07776262 - Korai 1. fázisTaking people68Ga-B7-H3 Nanobody ImmunoPET in Osteosarcoma
- Where
- Beijing
- Életkor
- 10 év to 80 év
- People
- 16
- Run by
- Peking University First Hospital
See details and how to joinNCT07774533 - 1. fázisTaking peopleA Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of B019 Injection in Subjects With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia.
- Where
- Beijing, Nanchang, Shanghai, Suzhou, Wuhan, Xuzhou
- Életkor
- 3 év to 25 év
- People
- 33
- Run by
- Shanghai Pharmaceutical Group Biological Therapy Technology Co., Ltd.
See details and how to joinNCT06927466 - 2. fázisTaking peopleOmission of Adjuvant Radiotherapy in Young Low-Risk Ductal Carcinoma In Situ Following Breast-Conserving Surgery
- Where
- Shanghai
- Életkor
- Up to 40 év
- People
- 234
- Run by
- Fudan University
See details and how to joinNCT07762924 - No phaseTaking peopleIntermediate-dose HAD Regimen for CEBPA Double-mutated AML
- Where
- Tianjin
- Életkor
- 14 év to 54 év
- People
- 148
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06529250 - No phaseTaking peopleMRD-positive AML Clinical Study
- Where
- Tianjin
- Életkor
- 14 év and over
- People
- 537
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07131059 - 1. fázisTaking peopleMetformin Inhibits DNMT3A Clonal Hematopoiesis in Acute Leukemia
- Where
- Tianjin
- Életkor
- 14 év and over
- People
- 32
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07188740 - No phaseTaking peoplePediatric-Inspired Regimen Combined With Venetoclax and Immunotherapy for Adult Ph-Negative Acute Lymphoblastic Leukemia
- Where
- Tianjin
- Életkor
- 14 év to 60 év
- People
- 43
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07495631 - No phaseTaking peopleMulticenter, Platform-type Clinical Study of Refractory/Recurrent Acute Myeloid Leukemia
- Where
- Tianjin
- People
- 458
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06265545 - 3. fázisTaking peopleStandard-dose vs Intermediate-dose Cytarabine Induction in the Treatment of Acute Myeloid Leukemia With RUNX1-RUNX1T1
- Where
- Tianjin
- Életkor
- 14 év to 60 év
- People
- 284
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06744504 - No phaseTaking peopleVenetoclax, Azacitidine and Liposomal Mitoxantrone for Newly Diagnosed AML
- Where
- Tianjin
- Életkor
- 14 év to 100 év
- People
- 27
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07490288 - No phaseNot yet taking people in KínaPlasma ctDNA Monitoring in Pediatric Acute Leukemia
- Where
- Tianjin
- Életkor
- 3 év to 18 év
- People
- 25
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07751588 - No phaseTaking peopleVenetoclax TDM in Newly Diagnosed AML: Exposure-Response and Prognosis
- Where
- Suzhou
- Életkor
- 16 év and over
- People
- 50
- Run by
- The First Affiliated Hospital of Soochow University
See details and how to joinNCT07670130 - No phaseNot yet taking people in KínaEffects of a Large Language Model-Driven Chatbot on Reproductive Concerns After Cancer
- Where
- Hefei
- Életkor
- 15 év to 39 év
- People
- 60 worldwide
- Run by
- The Hong Kong Polytechnic University
See details and how to joinNCT07741266 - No phaseNot yet taking people in KínaClinical Application Value of Deep Learning-Based "Opportunistic Screening" for Malignant Tumors on Routine Non-Contrast Chest-Abdomen-Pelvis CT
- Where
- Wuhan
- People
- 100 000
- Run by
- Lian Yang
See details and how to joinNCT07639567 - 2. fázisTaking peopleOrelabrutinib Plus Lisaftoclax and Rituximab in Untreated Mantle Cell Lymphoma With High-Risk Disease
- Where
- Shanghai
- Életkor
- 14 év and over
- People
- 25
- Run by
- Ruijin Hospital
See details and how to joinNCT07272499 - 3. fázisTaking peoplePhase III Clinical Study of VC004 in Patients With Localized Advanced/ Metastatic Solid Tumors
- Where
- Beijing
- Életkor
- 12 év and over
- People
- 54
- Run by
- Jiangsu vcare pharmaceutical technology co., LTD
See details and how to joinNCT06658353 - No phaseCsak meghívásosComparison of the Effect of Surgical Resection Based on Lesion Extent Before and After Neoadjuvant Therapy in Patients With Stage II-IIIB Non-Small Cell Lung Cancer: A Single-Center, Real-World, Open-Label Study
- Where
- Beijing
- People
- 354
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07373899 - 2. fázisTaking peoplePhase II Study of QLC2519 in Pediatric Solid Tumor Participants
- Where
- Beijing
- Életkor
- 0 év to 18 év
- People
- 18
- Run by
- Qilu Pharmaceutical Co., Ltd.
See details and how to joinNCT07724756 - No phaseTaking peopleProspective Evaluation of Dynamic Serum ProGRP for Treatment Response Monitoring in Ewing Sarcoma
- Where
- Beijing
- Életkor
- 10 év to 60 év
- People
- 100
- Run by
- Peking University People's Hospital
See details and how to joinNCT07725783 - 3. fázisTaking peopleA Study of Olverembatinib in SDH-deficient GIST.
- Where
- Guangzhou
- Életkor
- 12 év and over
- People
- 40
- Run by
- Ascentage Pharma Group Inc.
See details and how to joinNCT06640361